• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟酸受体 HCAR2 的变构配体选择性和变构探针依赖性。

Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2.

机构信息

Department of Otolaryngology Head and Neck Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610000, China.

Division of Nephrology and Kidney Research Institute, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.

出版信息

Signal Transduct Target Ther. 2023 Sep 25;8(1):364. doi: 10.1038/s41392-023-01625-y.

DOI:10.1038/s41392-023-01625-y
PMID:37743365
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10518311/
Abstract

Hydroxycarboxylic acid receptor 2 (HCAR2), a member of Class A G-protein-coupled receptor (GPCR) family, plays a pivotal role in anti-lipolytic and anti-inflammatory effects, establishing it as a significant therapeutic target for treating dyslipidemia and inflammatory diseases. However, the mechanism underlying the signaling of HCAR2 induced by various types of ligands remains elusive. In this study, we elucidate the cryo-electron microscopy (cryo-EM) structure of G-coupled HCAR2 in complex with a selective agonist, MK-6892, resolved to a resolution of 2.60 Å. Our structural analysis reveals that MK-6892 occupies not only the orthosteric binding pocket (OBP) but also an extended binding pocket (EBP) within HCAR2. Pharmacological assays conducted in this study demonstrate that the OBP is a critical determinant for ligand selectivity among the HCARs subfamily. Moreover, we investigate the pharmacological properties of the allosteric modulator compound 9n, revealing its probe-dependent behavior on HCAR2 in response to varying orthosteric agonists. Collectively, our findings provide invaluable structural insights that contribute to a deeper understanding of the regulatory mechanisms governing HCAR2 signaling transduction mediated by both orthosteric and allosteric ligands.

摘要

羟基羧酸受体 2(HCAR2)是 A 类 G 蛋白偶联受体(GPCR)家族的成员,在抗脂肪分解和抗炎作用中发挥着关键作用,使其成为治疗血脂异常和炎症性疾病的重要治疗靶点。然而,各种配体诱导的 HCAR2 信号转导的机制仍不清楚。在这项研究中,我们阐明了与选择性激动剂 MK-6892 结合的 G 偶联 HCAR2 的冷冻电子显微镜(cryo-EM)结构,分辨率为 2.60Å。我们的结构分析表明,MK-6892 不仅占据了 HCAR2 的正位结合口袋(OBP),还占据了一个扩展的结合口袋(EBP)。本研究中的药理学研究表明,OBP 是 HCAR 亚家族中配体选择性的关键决定因素。此外,我们研究了变构调节剂化合物 9n 的药理学特性,揭示了其在不同正位激动剂存在下对 HCAR2 的探针依赖性行为。总之,我们的研究结果提供了宝贵的结构见解,有助于深入了解正位和变构配体介导的 HCAR2 信号转导的调节机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1479/10518311/f30ee40c3d70/41392_2023_1625_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1479/10518311/cf627f7f4659/41392_2023_1625_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1479/10518311/66116ef25384/41392_2023_1625_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1479/10518311/55683e2ad651/41392_2023_1625_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1479/10518311/f30ee40c3d70/41392_2023_1625_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1479/10518311/cf627f7f4659/41392_2023_1625_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1479/10518311/66116ef25384/41392_2023_1625_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1479/10518311/55683e2ad651/41392_2023_1625_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1479/10518311/f30ee40c3d70/41392_2023_1625_Fig4_HTML.jpg

相似文献

1
Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2.羟酸受体 HCAR2 的变构配体选择性和变构探针依赖性。
Signal Transduct Target Ther. 2023 Sep 25;8(1):364. doi: 10.1038/s41392-023-01625-y.
2
Molecular recognition of niacin and lipid-lowering drugs by the human hydroxycarboxylic acid receptor 2.人源羟羧酸受体 2 对烟酸和降脂药物的分子识别。
Cell Rep. 2023 Nov 28;42(11):113406. doi: 10.1016/j.celrep.2023.113406. Epub 2023 Nov 11.
3
Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation.别构激活酮体受体 HCAR2 抑制炎症。
Mol Cell. 2023 Sep 7;83(17):3171-3187.e7. doi: 10.1016/j.molcel.2023.07.030. Epub 2023 Aug 18.
4
Orthosteric and allosteric modulation of human HCAR2 signaling complex.人源 HCAR2 信号复合物的变构调节和变构调节。
Nat Commun. 2023 Nov 22;14(1):7620. doi: 10.1038/s41467-023-43537-z.
5
Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2.关于人类羟基羧酸受体HCAR2的配体识别和选择性的结构见解。
Cell Discov. 2023 Nov 28;9(1):118. doi: 10.1038/s41421-023-00610-7.
6
Structural basis for ligand recognition and signaling of hydroxy-carboxylic acid receptor 2.羟基羧酸受体 2 的配体识别和信号转导的结构基础。
Nat Commun. 2023 Nov 6;14(1):7150. doi: 10.1038/s41467-023-42764-8.
7
Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode.多个最近的 HCAR2 结构展示了一个高度动态的配体结合和 G 蛋白激活模式。
Nat Commun. 2024 Jun 25;15(1):5364. doi: 10.1038/s41467-024-49536-y.
8
How Do Modulators Affect the Orthosteric and Allosteric Binding Pockets?调节剂如何影响变构结合口袋和正构结合口袋?
ACS Chem Neurosci. 2022 Apr 6;13(7):959-977. doi: 10.1021/acschemneuro.1c00749. Epub 2022 Mar 17.
9
Cryo-EM structure of the human adenosine A receptor-G signaling complex.人源腺苷 A 受体-G 信号复合物的冷冻电镜结构。
Sci Adv. 2022 Dec 23;8(51):eadd3709. doi: 10.1126/sciadv.add3709.
10
Ligand recognition and biased agonism of the D1 dopamine receptor.配体识别与 D1 多巴胺受体的偏激动效应。
Nat Commun. 2022 Jun 8;13(1):3186. doi: 10.1038/s41467-022-30929-w.

引用本文的文献

1
Insights into the Activation Mechanism of HCA1, HCA2, and HCA3.对HCA1、HCA2和HCA3激活机制的见解。
J Med Chem. 2025 Feb 27;68(4):4527-4539. doi: 10.1021/acs.jmedchem.4c02567. Epub 2025 Feb 12.
2
Molecular simulations reveal intricate coupling between agonist-bound β-adrenergic receptors and G protein.分子模拟揭示了激动剂结合的β-肾上腺素能受体与G蛋白之间的复杂耦合。
iScience. 2025 Jan 2;28(2):111741. doi: 10.1016/j.isci.2024.111741. eCollection 2025 Feb 21.
3
Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode.

本文引用的文献

1
Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation.别构激活酮体受体 HCAR2 抑制炎症。
Mol Cell. 2023 Sep 7;83(17):3171-3187.e7. doi: 10.1016/j.molcel.2023.07.030. Epub 2023 Aug 18.
2
Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84.结构洞察配体识别和激活中链脂肪酸感应受体 GPR84。
Nat Commun. 2023 Jun 6;14(1):3271. doi: 10.1038/s41467-023-38985-6.
3
Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator.
多个最近的 HCAR2 结构展示了一个高度动态的配体结合和 G 蛋白激活模式。
Nat Commun. 2024 Jun 25;15(1):5364. doi: 10.1038/s41467-024-49536-y.
4
Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1.基于结构的大麻素受体 CB1 的 G 蛋白偏向性变构调节剂的鉴定。
Proc Natl Acad Sci U S A. 2024 Jun 11;121(24):e2321532121. doi: 10.1073/pnas.2321532121. Epub 2024 Jun 3.
5
G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery.G 蛋白偶联受体(GPCRs):结构、机制和药物发现方面的进展。
Signal Transduct Target Ther. 2024 Apr 10;9(1):88. doi: 10.1038/s41392-024-01803-6.
6
Structure-guided engineering of biased-agonism in the human niacin receptor via single amino acid substitution.通过单氨基酸取代对人烟酸受体中偏向激动作用进行结构导向工程改造。
Nat Commun. 2024 Mar 2;15(1):1939. doi: 10.1038/s41467-024-46239-2.
7
Structure, function and drug discovery of GPCR signaling.G蛋白偶联受体(GPCR)信号传导的结构、功能与药物发现
Mol Biomed. 2023 Dec 4;4(1):46. doi: 10.1186/s43556-023-00156-w.
与偏向性变构调节剂结合的复合物中揭示的神经降压素受体变构作用
Biochemistry. 2023 Apr 4;62(7):1233-1248. doi: 10.1021/acs.biochem.3c00029. Epub 2023 Mar 14.
4
Allosteric modulation of G protein-coupled receptor signaling.变构调节 G 蛋白偶联受体信号转导。
Front Endocrinol (Lausanne). 2023 Feb 16;14:1137604. doi: 10.3389/fendo.2023.1137604. eCollection 2023.
5
Unsaturated bond recognition leads to biased signal in a fatty acid receptor.不饱和键识别导致脂肪酸受体信号偏向。
Science. 2023 Apr 7;380(6640):eadd6220. doi: 10.1126/science.add6220.
6
Structure-based design of bitopic ligands for the µ-opioid receptor.基于结构的μ-阿片受体双位点配体设计。
Nature. 2023 Jan;613(7945):767-774. doi: 10.1038/s41586-022-05588-y. Epub 2022 Nov 30.
7
Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.吗啡和芬太尼与人 μ 阿片受体的分子识别。
Cell. 2022 Nov 10;185(23):4361-4375.e19. doi: 10.1016/j.cell.2022.09.041.
8
Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1.大麻素受体 CB1 的变构调节的分子机制。
Nat Chem Biol. 2022 Aug;18(8):831-840. doi: 10.1038/s41589-022-01038-y. Epub 2022 May 30.
9
Lipid21: Complex Lipid Membrane Simulations with AMBER.Lipid21:用 AMBER 进行复杂脂质膜模拟。
J Chem Theory Comput. 2022 Mar 8;18(3):1726-1736. doi: 10.1021/acs.jctc.1c01217. Epub 2022 Feb 3.
10
New tools for automated cryo-EM single-particle analysis in RELION-4.0.用于 RELION-4.0 自动化冷冻电镜单颗粒分析的新工具。
Biochem J. 2021 Dec 22;478(24):4169-4185. doi: 10.1042/BCJ20210708.